- Home
- GNL vs RXRX Comparison
GNL vs RXRX Comparison
Compare GNL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNL
- RXRX
- Stock Information
- Founded
- GNL 2011
- RXRX 2013
- Country
- GNL United States
- RXRX United States
- Employees
- GNL N/A
- RXRX N/A
- Industry
- GNL Real Estate Investment Trusts
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- GNL Real Estate
- RXRX Health Care
- Exchange
- GNL Nasdaq
- RXRX Nasdaq
- Market Cap
- GNL 1.7B
- RXRX 2.0B
- IPO Year
- GNL N/A
- RXRX 2021
- Fundamental
- Price
- GNL $7.76
- RXRX $5.25
- Analyst Decision
- GNL Buy
- RXRX Buy
- Analyst Count
- GNL 3
- RXRX 5
- Target Price
- GNL $9.00
- RXRX $7.00
- AVG Volume (30 Days)
- GNL 2.1M
- RXRX 32.1M
- Earning Date
- GNL 08-05-2025
- RXRX 08-07-2025
- Dividend Yield
- GNL 9.79%
- RXRX N/A
- EPS Growth
- GNL N/A
- RXRX N/A
- EPS
- GNL N/A
- RXRX N/A
- Revenue
- GNL $789,545,000.00
- RXRX $59,790,000.00
- Revenue This Year
- GNL N/A
- RXRX $23.51
- Revenue Next Year
- GNL N/A
- RXRX $53.87
- P/E Ratio
- GNL N/A
- RXRX N/A
- Revenue Growth
- GNL 38.85
- RXRX 29.32
- 52 Week Low
- GNL $6.51
- RXRX $3.79
- 52 Week High
- GNL $9.11
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- GNL 57.36
- RXRX 55.15
- Support Level
- GNL $7.32
- RXRX $4.91
- Resistance Level
- GNL $7.75
- RXRX $5.44
- Average True Range (ATR)
- GNL 0.16
- RXRX 0.36
- MACD
- GNL 0.04
- RXRX 0.01
- Stochastic Oscillator
- GNL 94.07
- RXRX 72.37
About GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operating, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution; Multi-Tenant Retail; Single-Tenant Retail; and office. The company derives maximum revenue from industrial and distribution segment. The company geographically operates in Unites States, United Kingdom, Canada and Europe.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.